chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site rash, Vaccination site swelling
Clinical narrative: injection site turned red; Slight amount of swelling; tender to the touch; confluent rash; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE ERYTHEMA (injection site turned red), VACCINATION SITE SWELLING (Slight amount of swelling), VACCINATION SITE PAIN (tender to the touch) and VACCINATION SITE RASH (confluent rash) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN, RANOLAZINE (RANEXA), CARBIDOPA, LEVODOPA (SINEMET), DONEPEZIL HYDROCHLORIDE (ARICEPT), ACETYLSALICYLIC ACID (BABY ASPIRIN), VITAMIN D NOS, MULTIVITAMINS;MINERALS, METFORMIN and METOPROLOL for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site turned red), VACCINATION SITE SWELLING (Slight amount of swelling), VACCINATION SITE PAIN (tender to the touch) and VACCINATION SITE RASH (confluent rash). At the time of the report, VACCINATION SITE ERYTHEMA (injection site turned red), VACCINATION SITE SWELLING (Slight amount of swelling), VACCINATION SITE PAIN (tender to the touch) and VACCINATION SITE RASH (confluent rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; A spontaneous report was received from a consumer concerning a 87-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events diarrhea.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 27 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: 039A20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 28 Jan 2021, the patient experienced the event diarrhea.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events include, diarrhea was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, Pruritus, Vaccination site induration, Vaccination site pain
Clinical narrative: diarrhea; injection site warmth; Nausea; injection site pain; injection site swelling; injection site lump; itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching), DIARRHOEA (diarrhea), VACCINATION SITE WARMTH (injection site warmth), NAUSEA (Nausea) and VACCINATION SITE PAIN (injection site pain) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PRURITUS (itching). On 01-Feb-2021, the patient experienced DIARRHOEA (diarrhea), VACCINATION SITE WARMTH (injection site warmth), NAUSEA (Nausea), VACCINATION SITE PAIN (injection site pain), VACCINATION SITE SWELLING (injection site swelling) and VACCINATION SITE INDURATION (injection site lump). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 01-Feb-2001, NAUSEA (Nausea) had resolved. On 27-Jan-2021, PRURITUS (itching) had resolved. On 01-Feb-2021, DIARRHOEA (diarrhea) had resolved. At the time of the report, VACCINATION SITE WARMTH (injection site warmth), VACCINATION SITE PAIN (injection site pain), VACCINATION SITE SWELLING (injection site swelling) and VACCINATION SITE INDURATION (injection site lump) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant treatment was not reported.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: diarrhea; injection site warmth; Nausea; injection site pain; injection site swelling; injection site lump; itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching), DIARRHOEA (diarrhea), VACCINATION SITE WARMTH (injection site warmth), NAUSEA (Nausea) and VACCINATION SITE PAIN (injection site pain) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PRURITUS (itching). On 01-Feb-2021, the patient experienced DIARRHOEA (diarrhea), VACCINATION SITE WARMTH (injection site warmth), NAUSEA (Nausea), VACCINATION SITE PAIN (injection site pain), VACCINATION SITE SWELLING (injection site swelling) and VACCINATION SITE INDURATION (injection site lump). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 01-Feb-2001, NAUSEA (Nausea) had resolved. On 27-Jan-2021, PRURITUS (itching) had resolved. On 01-Feb-2021, DIARRHOEA (diarrhea) had resolved. At the time of the report, VACCINATION SITE WARMTH (injection site warmth), VACCINATION SITE PAIN (injection site pain), VACCINATION SITE SWELLING (injection site swelling) and VACCINATION SITE INDURATION (injection site lump) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant treatment was not reported.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: body ache; 99°F fever; Chills; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body ache), HEADACHE (headache), FATIGUE (fatigue), PYREXIA (99°F fever) and CHILLS (Chills) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     Concomitant products included SUMATRIPTAN SUCCINATE (IMITREX DF) for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced HEADACHE (headache) and FATIGUE (fatigue). On 13-Jan-2021, the patient experienced MYALGIA (body ache), PYREXIA (99°F fever) and CHILLS (Chills). On 13-Jan-2021, FATIGUE (fatigue) had resolved. On 14-Jan-2021, MYALGIA (body ache), HEADACHE (headache), PYREXIA (99°F fever) and CHILLS (Chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Hypertension, Respiratory rate increased
Clinical narrative: Breathing faster; Little fatigue in his legs; Blood pressure was higher than normal; A spontaneous report was received from a Healthcare Professional concerning a 72-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events breathing faster, little fatigue in his legs, blood pressure was higher than normal.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 1 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: 027LZ0A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 1 Feb 2021, the patient experienced the events breathing faster. little fatigue in his legs, blood pressure was higher than normal.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events include, breathing faster, little fatigue in his legs, blood pressure was higher than normal was not reported.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Headache, Nausea
Clinical narrative: No Appetite; Nausea; Cold Chills; Tiredness; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 19-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (No Appetite), NAUSEA (Nausea), CHILLS (Cold Chills), FATIGUE (Tiredness) and HEADACHE (Headache) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00UM20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced DECREASED APPETITE (No Appetite), NAUSEA (Nausea), CHILLS (Cold Chills), FATIGUE (Tiredness) and HEADACHE (Headache). At the time of the report, DECREASED APPETITE (No Appetite), NAUSEA (Nausea), CHILLS (Cold Chills), FATIGUE (Tiredness) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: No specific follow-up information recorded.
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: experiencing flu-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (experiencing flu-like symptoms) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction (No reported medical history).    On 12-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (experiencing flu-like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (experiencing flu-like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided. No treatment details reported.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (vaccination site pain) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE PAIN (vaccination site pain). At the time of the report, VACCINATION SITE PAIN (vaccination site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment details are provided.   This case was linked to MOD-2021-021672.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Immunisation reaction
Clinical narrative: Reaction to immunization; This spontaneous case was reported by a health care professional and describes the occurrence of IMMUNISATION REACTION (Reaction to immunization) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Reaction to immunization). At the time of the report, IMMUNISATION REACTION (Reaction to immunization) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.  Concomitant product use was unknown by the reporter.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Rosacea
Clinical narrative: rosacea was aggravated; This spontaneous case was reported by a consumer and describes the occurrence of ROSACEA (rosacea was aggravated) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included T-cell lymphoma (6 or 7 years) and Rosacea.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced ROSACEA (rosacea was aggravated). The patient was treated with DOXYCYCLINE for Rosacea, at a dose of was prescribed doxycycline, 30 days supply and METRONIDAZOLE for Rosacea, at an unspecified dose and frequency. At the time of the report, ROSACEA (rosacea was aggravated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient taking doxycycline and metronidazole cream as corrective treatment . There is no product complaint associated with this case. There is no concomitant list Reportedly the patient's blood counts were relatively stable. He went to the dermatologist on 25-Jan-2021.He was prescribed doxycycline, 30 day supply and metronidazole cream. Consent given.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced DIARRHOEA (Diarrhea). On 01-Feb-2021, DIARRHOEA (Diarrhea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products were not provided.Treatment information was not provided. There is no product complaint associated with this case
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and HEADACHE (Headache) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.  On 10-Feb-2021, the patient experienced PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, PYREXIA (Fever) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No corrective treatment and concomitant medications was reported There is no product complaint associated with this case
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Myalgia, Nausea, Pyrexia
Clinical narrative: diarrhea; still running a slight temperature, feverish; body aches, ache every where; feels tired and not having fun; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), PYREXIA (still running a slight temperature, feverish), MYALGIA (body aches, ache every where), FATIGUE (feels tired and not having fun) and NAUSEA (nauseous) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea), PYREXIA (still running a slight temperature, feverish), MYALGIA (body aches, ache every where), FATIGUE (feels tired and not having fun) and NAUSEA (nauseous). The patient was treated with NAPROXEN for Myalgia, at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea), FATIGUE (feels tired and not having fun) and NAUSEA (nauseous) outcome was unknown and PYREXIA (still running a slight temperature, feverish) and MYALGIA (body aches, ache every where) had not resolved.            Concomitant medications were not provided. The patient received unspecified treatment medication for diarrhea.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Nausea, Tremor, Vomiting
Clinical narrative: shaking; chills; vomiting; nausea; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking), CHILLS (chills), VOMITING (vomiting) and NAUSEA (nausea) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     No Medical History information was reported.   On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced TREMOR (shaking), CHILLS (chills), VOMITING (vomiting) and NAUSEA (nausea). At the time of the report, TREMOR (shaking), CHILLS (chills), VOMITING (vomiting) and NAUSEA (nausea) outcome was unknown. Not Provided          No relevant concomitant medications were reported.  Treatment information was not provided.  Action taken with mRNA-123 is not applicable.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: Tongue became tingley; A spontaneous report was received from a consumer concerning a 59-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced tongue became tingly.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 23 Jan 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (lot batch: 013L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 23 Jan 2021, the patient states about 15 or 20 min after getting (vaccine) injected, the tongue became tingly that lasted several hours.  No treatment medication were provided.  Action taken with mRNA-1273 in response to the event was not reported.   On an unknown date, the outcome of event tongue became tingly was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dyspnoea, Fatigue, Headache, Heart rate
Clinical narrative: Rapid heart beat; Too sick; Unable to get up; Difficulty breathy; Bad headaches; Fever/ 101.4; Body aches; Little nausea; Exhausted/fatigued; This spontaneous case was reported by a nurse and describes the occurrence of HEART RATE INCREASED (Rapid heart beat), ILLNESS (Too sick), MALAISE (Unable to get up), DYSPNOEA (Difficulty breathy) and HEADACHE (Bad headaches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Rapid heart beat), ILLNESS (Too sick), MALAISE (Unable to get up), DYSPNOEA (Difficulty breathy), HEADACHE (Bad headaches), PYREXIA (Fever/ 101.4), MYALGIA (Body aches), NAUSEA (Little nausea) and FATIGUE (Exhausted/fatigued). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEART RATE INCREASED (Rapid heart beat), ILLNESS (Too sick), MALAISE (Unable to get up), DYSPNOEA (Difficulty breathy), HEADACHE (Bad headaches), PYREXIA (Fever/ 101.4), MYALGIA (Body aches), NAUSEA (Little nausea) and FATIGUE (Exhausted/fatigued) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Feb-2021, Body temperature: 101.4 High. On 15-Feb-2021, Heart rate: High.          Concomitant product use was not provided.  Action taken with mRNA-123 is not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 19-Feb-2021: No specific follow-up information recorded.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Illness, Malaise, Myalgia, Nausea
Clinical narrative: Rapid heart beat; Too sick; Unable to get up; Difficulty breathy; Bad headaches; Fever/ 101.4; Body aches; Little nausea; Exhausted/fatigued; This spontaneous case was reported by a nurse and describes the occurrence of HEART RATE INCREASED (Rapid heart beat), ILLNESS (Too sick), MALAISE (Unable to get up), DYSPNOEA (Difficulty breathy) and HEADACHE (Bad headaches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Rapid heart beat), ILLNESS (Too sick), MALAISE (Unable to get up), DYSPNOEA (Difficulty breathy), HEADACHE (Bad headaches), PYREXIA (Fever/ 101.4), MYALGIA (Body aches), NAUSEA (Little nausea) and FATIGUE (Exhausted/fatigued). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEART RATE INCREASED (Rapid heart beat), ILLNESS (Too sick), MALAISE (Unable to get up), DYSPNOEA (Difficulty breathy), HEADACHE (Bad headaches), PYREXIA (Fever/ 101.4), MYALGIA (Body aches), NAUSEA (Little nausea) and FATIGUE (Exhausted/fatigued) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Feb-2021, Body temperature: 101.4 High. On 15-Feb-2021, Heart rate: High.          Concomitant product use was not provided.  Action taken with mRNA-123 is not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 19-Feb-2021: No specific follow-up information recorded.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Rapid heart beat; Too sick; Unable to get up; Difficulty breathy; Bad headaches; Fever/ 101.4; Body aches; Little nausea; Exhausted/fatigued; This spontaneous case was reported by a nurse and describes the occurrence of HEART RATE INCREASED (Rapid heart beat), ILLNESS (Too sick), MALAISE (Unable to get up), DYSPNOEA (Difficulty breathy) and HEADACHE (Bad headaches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Rapid heart beat), ILLNESS (Too sick), MALAISE (Unable to get up), DYSPNOEA (Difficulty breathy), HEADACHE (Bad headaches), PYREXIA (Fever/ 101.4), MYALGIA (Body aches), NAUSEA (Little nausea) and FATIGUE (Exhausted/fatigued). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEART RATE INCREASED (Rapid heart beat), ILLNESS (Too sick), MALAISE (Unable to get up), DYSPNOEA (Difficulty breathy), HEADACHE (Bad headaches), PYREXIA (Fever/ 101.4), MYALGIA (Body aches), NAUSEA (Little nausea) and FATIGUE (Exhausted/fatigued) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Feb-2021, Body temperature: 101.4 High. On 15-Feb-2021, Heart rate: High.          Concomitant product use was not provided.  Action taken with mRNA-123 is not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 19-Feb-2021: No specific follow-up information recorded.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of diarrhea and headache in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Jan 24, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jan 24, 2021, patient experienced diarrhea and headache. At the time of the report, diarrhea and headache outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications or treatment information provided. This case linked to MOD-2021-017362, MOD-2021-018737 (patient link).
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased
Clinical narrative: Two hours after receiving the shot ,blood sugar levels were higher than the normal; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (Two hours after receiving the shot ,blood sugar levels were higher than the normal) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included TRAMADOL for Pain.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced BLOOD GLUCOSE INCREASED (Two hours after receiving the shot ,blood sugar levels were higher than the normal). At the time of the report, BLOOD GLUCOSE INCREASED (Two hours after receiving the shot ,blood sugar levels were higher than the normal) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Feb-2021, Blood glucose increased: 156 mg/dl (High) Patient usually has blood sugar in the range 99-120 mg/dl.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications also include 2 different injections for diabetes a day.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Injection site inflammation, Injection site pain, Injection site pruritus
Clinical narrative: flared up; itchy; pain; This spontaneous case was reported by a health care professional and describes the occurrence of INJECTION SITE INFLAMMATION (flared up), INJECTION SITE PRURITUS (itchy) and INJECTION SITE PAIN (pain) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 immunization.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 14-Jan-2021, the patient experienced INJECTION SITE PRURITUS (itchy) and INJECTION SITE PAIN (pain). On an unknown date, the patient experienced INJECTION SITE INFLAMMATION (flared up). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INJECTION SITE INFLAMMATION (flared up), INJECTION SITE PRURITUS (itchy) and INJECTION SITE PAIN (pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   The treatment information provided includes Paracetamol.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: 9 days after the shot, little bit warm where I got the vaccine (delayed reaction); 9 days after the shot, red spot 2 inches high and 3 inches wide where I got shot (delayed reaction); Feelimg tired; arm hurt; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (9 days after the shot, little bit warm where I got the vaccine (delayed reaction)), FATIGUE (Feelimg tired), VACCINATION SITE PAIN (arm hurt) and VACCINATION SITE ERYTHEMA (9 days after the shot, red spot 2 inches high and 3 inches wide where I got shot (delayed reaction)) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced FATIGUE (Feelimg tired) and VACCINATION SITE PAIN (arm hurt). On 26-Jan-2021, the patient experienced VACCINATION SITE WARMTH (9 days after the shot, little bit warm where I got the vaccine (delayed reaction)) and VACCINATION SITE ERYTHEMA (9 days after the shot, red spot 2 inches high and 3 inches wide where I got shot (delayed reaction)). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency and CORTISONE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (9 days after the shot, little bit warm where I got the vaccine (delayed reaction)), FATIGUE (Feelimg tired) and VACCINATION SITE ERYTHEMA (9 days after the shot, red spot 2 inches high and 3 inches wide where I got shot (delayed reaction)) outcome was unknown and VACCINATION SITE PAIN (arm hurt) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: iNarrative supplement updated, reporter details updated
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: arm ached; tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (arm ached) and FATIGUE (tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (arm ached) and FATIGUE (tired). At the time of the report, PAIN (arm ached) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications  were not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD21-034947 (Patient Link).
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Product availability issue
Clinical narrative: Scheduled 2nd dose but did not received it/No vaccines left at the facility; Chest pain; Felt slightly dizzy; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain), DIZZINESS (Felt slightly dizzy) and PRODUCT AVAILABILITY ISSUE (Scheduled 2nd dose but did not received it/No vaccines left at the facility) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis and Thyroid disorder. Concomitant products included LEUPRORELIN ACETATE (LUPRON).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 21-Jan-2021, the patient experienced CHEST PAIN (Chest pain) and DIZZINESS (Felt slightly dizzy). On 17-Feb-2021, the patient experienced PRODUCT AVAILABILITY ISSUE (Scheduled 2nd dose but did not received it/No vaccines left at the facility). The patient was treated with PARACETAMOL (TYNELOL) on 23-Jan-2021 at an unspecified dose and frequency. On 21-Jan-2021, CHEST PAIN (Chest pain) and DIZZINESS (Felt slightly dizzy) had resolved. At the time of the report, PRODUCT AVAILABILITY ISSUE (Scheduled 2nd dose but did not received it/No vaccines left at the facility) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        Relevant concomitant medications were reported as tynelol for arthritis, thyroid medication, cholesterol medication, vitamins, lupricon vaccine for every 3 months 0r 6months depending on results.    Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Vaccination adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Vaccination adverse reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination adverse reaction). At the time of the report, VACCINATION COMPLICATION (Vaccination adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment information was reported.
Sex: M
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Pain in extremity
Clinical narrative: Arm and shoulder area are hurting; Worse in the mornings; can't raise his arm; This spontaneous case was reported by a physician assistant and describes the occurrence of PAIN IN EXTREMITY (Arm and shoulder area are hurting), PAIN IN EXTREMITY (Worse in the mornings) and INJECTED LIMB MOBILITY DECREASED (can't raise his arm) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 immunization.     no medical history reported.     On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm and shoulder area are hurting), PAIN IN EXTREMITY (Worse in the mornings) and INJECTED LIMB MOBILITY DECREASED (can't raise his arm). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm and shoulder area are hurting), PAIN IN EXTREMITY (Worse in the mornings) and INJECTED LIMB MOBILITY DECREASED (can't raise his arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications used by the patient were not provided.   Reporter did not allow further contact
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain in extremity, Rhinorrhoea, Throat irritation
Clinical narrative: nose started running; Chills; Left arm pain; Scratchy throat; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (Scratchy throat), RHINORRHOEA (nose started running), CHILLS (Chills) and PAIN IN EXTREMITY (Left arm pain) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced THROAT IRRITATION (Scratchy throat). On an unknown date, the patient experienced RHINORRHOEA (nose started running), CHILLS (Chills) and PAIN IN EXTREMITY (Left arm pain). On 19-Feb-2021, THROAT IRRITATION (Scratchy throat) outcome was unknown. At the time of the report, RHINORRHOEA (nose started running), CHILLS (Chills) and PAIN IN EXTREMITY (Left arm pain) outcome was unknown.            Concomitant product use was not provided. Treatment information was not provided. Action taken with the mRNA-1273 in response to event is Not Applicable.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Pruritus, Skin warm, Urticaria
Clinical narrative: Welt almost like hives; Red welt; Itchy welt; Arm was sore; Arm was warm to the touch; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), SKIN WARM (Arm was warm to the touch), URTICARIA (Welt almost like hives), ERYTHEMA (Red welt) and PRURITUS (Itchy welt) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).    On 30-Dec-2020 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced PAIN IN EXTREMITY (Arm was sore) and SKIN WARM (Arm was warm to the touch). In January 2021, the patient experienced URTICARIA (Welt almost like hives), ERYTHEMA (Red welt) and PRURITUS (Itchy welt). In January 2021, URTICARIA (Welt almost like hives), ERYTHEMA (Red welt) and PRURITUS (Itchy welt) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm was sore) and SKIN WARM (Arm was warm to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment for the events included Benadryl.; Sender's Comments: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Hot; Intense itchiness on the injection site; Bumpy rash size of a quarter on the injection site; Swelling the size of golf ball; Red and hot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot), VACCINATION SITE PRURITUS (Intense itchiness on the injection site), VACCINATION SITE RASH (Bumpy rash size of a quarter on the injection site), VACCINATION SITE SWELLING (Swelling the size of golf ball) and VACCINATION SITE ERYTHEMA (Red and hot) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     The patient's past medical history included Hypothyroidism (PMH includes hypothyroidism.). Concurrent medical conditions included Allergy (Denies allergies). Concomitant products included LEVOTHYROXINE for Hypothyroidism.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot), VACCINATION SITE PRURITUS (Intense itchiness on the injection site), VACCINATION SITE RASH (Bumpy rash size of a quarter on the injection site), VACCINATION SITE SWELLING (Swelling the size of golf ball) and VACCINATION SITE ERYTHEMA (Red and hot). At the time of the report, VACCINATION SITE WARMTH (Hot), VACCINATION SITE PRURITUS (Intense itchiness on the injection site), VACCINATION SITE RASH (Bumpy rash size of a quarter on the injection site), VACCINATION SITE SWELLING (Swelling the size of golf ball) and VACCINATION SITE ERYTHEMA (Red and hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment for the event was nor reported.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness in the arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in the arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness in the arm). At the time of the report, PAIN IN EXTREMITY (Soreness in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medication was not provided by reporter. Treatment information not provided.   This case was linked to MOD-2021-021769 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: body aches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (body aches). At the time of the report, MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Headache, Polymerase chain reaction, Pyrexia
Clinical narrative: Seems like he has COVID all over again; Difficulty breathing; Fever; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of SYMPTOM RECURRENCE (Seems like he has COVID all over again), DYSPNOEA (Difficulty breathing), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (14 days post symptomatic COVID-19 positive disease).    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced SYMPTOM RECURRENCE (Seems like he has COVID all over again), DYSPNOEA (Difficulty breathing), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, SYMPTOM RECURRENCE (Seems like he has COVID all over again), DYSPNOEA (Difficulty breathing), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Polymerase chain reaction: Positive. On an unknown date, Pyrexia: 101.1 f Fever 101.1 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Symptom recurrence
Clinical narrative: Seems like he has COVID all over again; Difficulty breathing; Fever; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of SYMPTOM RECURRENCE (Seems like he has COVID all over again), DYSPNOEA (Difficulty breathing), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (14 days post symptomatic COVID-19 positive disease).    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced SYMPTOM RECURRENCE (Seems like he has COVID all over again), DYSPNOEA (Difficulty breathing), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, SYMPTOM RECURRENCE (Seems like he has COVID all over again), DYSPNOEA (Difficulty breathing), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Polymerase chain reaction: Positive. On an unknown date, Pyrexia: 101.1 f Fever 101.1 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Puke; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Puke) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included BP normal (Blood pressure medium).    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced VOMITING (Puke). On 18-Feb-2021, VOMITING (Puke) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: high temperature of 99.6°F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (high temperature of 99.6°F) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced PYREXIA (high temperature of 99.6°F). At the time of the report, PYREXIA (high temperature of 99.6°F) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Body temperature: 99.6 degree f (High) 99.6 degree F.         Concomitant medications were not provided. Treatment information was not reported.